Factor VII activation, apolipoprotein A-I and reverse cholesterol transport: Possible relevance for postprandial lipaemia

Thrombosis and Haemostasis

Volumn 87, Issue 3, 2002, Pages 477-482

  Miller, George J ^a   Cooke, C J ^a   Nanjee, M N ^a   Howarth, D J ^a   Cooper, J A ^a   Stepanova, I P ^a   Morrissey, J H ^a   Miller, N E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apolipoprotein A I; Factor VII; High density lipoprotein; Phospholipids; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBIN ANTITHROMBIN COMPLEX; TRIACYLGLYCEROL; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; HDL CHOLESTERYL ESTER; PEPTIDE HYDROLASE;

ADULT; ARTICLE; BLOOD CLOTTING; BODY WEIGHT; CELL SURFACE; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INFUSION; LIPOPROTEIN BLOOD LEVEL; MALE; MEASUREMENT; METABOLIC ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; BLOOD; DRUG EFFECT; ENZYME ACTIVATION; KINETICS; METABOLISM; PHYSIOLOGY; POSTPRANDIAL STATE; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ANTITHROMBIN III; APOLIPOPROTEIN A-I; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL ESTERS; ENZYME ACTIVATION; FACTOR VII; HUMANS; HYPERLIPIDEMIAS; INFUSIONS, PARENTERAL; KINETICS; LIPOPROTEINS, HDL; MALE; PEPTIDE HYDROLASES; PHOSPHATIDYLCHOLINES; POSTPRANDIAL PERIOD;

EID: 0036119783     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613028     Document Type: Article

References (56)

1. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition
2. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis
3. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiency
4. Association between dietary fat intake and plasma factor VII activity - A predictor of cardiovascular mortality
5. Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: Effects on blood lipids, factor VII coagulant activity, and fibrinogen
6. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis
7. The inter-relationship of factor VII and its activity state with plasma lipids in healthy male adults
8. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels
9. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - Association with cholesterol and triglyceride levels
10. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man
11. Human chylomicron apolipoprotein metabolism
12. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects
13. Is cholesterol efflux from tissue regulated by lipolysis of triglyceride-rich lipoproteins?
14. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
15. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice
16. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells
17. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
18. Molecular physiology of reverse cholesterol transport
19. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
20. Transbilayer movement of phospholipids in red cell and platelet membranes
21. Specific contribution of different phospholipid surfaces to the activation of prothrombin by the fully assembled prothrombinase
22. Factor VII binding to tissue factor in reconstituted phospholipids: Induction of cooperativity by phosphatidylserine
23. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine
24. An endothelial cell-dependent pathway of coagulation
25. Presence of vitamin K-dependent coagulation proteins in isolated triglyceride-rich lipoproteins of human plasma
26. Interaction of vitamin K dependent proteins with membranes
27. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes
28. Plasma lipoproteins enhance tissue factor-independent factor VII activation
29. Assembly of the intrinsic factor X activating complex-interactions between factor IXa, factor VIIIa and phospholipid
30. Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-L-serine
31. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: Enhancement of sensitivity to phosphatidylserine
32. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces
33. Effects of postprandial lipemia on plasma cholesterol metabolism
34. Evidence that reverse cholesterol transport is stimulated by lipolysis of triglyceride-rich lipoproteins
35. Activation of human factor VII in plasma and purified systems. Roles of activated factor IX, kallikrein, and activated factor VII
36. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency
37. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway
38. Activation of human factor VII by activated factors IX and X
39. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications
40. Sequential microenzymatic assay of cholesterol, triglycerides, and phospholipids in a single aliquot
41. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein
42. Effects of intravenous infusion of lipid-free apoA-I in humans
43. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
44. Acute effects of intravenous infusion of apo A1/phosphatidycholine discs on plasma lipoproteins in humans
45. In vitro characteristics of reconstituted HDL for therapy
46. Is plasma high density lipoprotein concentration rate limiting for reverse cholesterol transport in humans in vivo?
47. Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion
48. The peroxisome proliferator-activated receptor: Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
49. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
50. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins
51. Cardiolipin is a normal component of human plasma lipoproteins
52. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype
53. The effects of structurally defined triglycerides of differing fatty acid composition on postprandial haemostasis in young healthy men
54. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis
55. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C
56. Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: Possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin